| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |